Medical Doctor Program year 2020 Reported 2019–2020 Source: CMS Open Payments, 2026 publication

Kirk Brody

Obstetrics & Gynecology Lakeland, FL Medical Doctor

NPI 1497720759 CMS profile 1060518

4444 S Florida Ave, Suite 403, Lakeland, FL 33813

Open in the dashboard

General payments

$10,883

35 records reported · program years 2019–2020

Research payments

$5,688

Paid to them · 1 record reported · program years 2019–2020

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,396,236 paid to institutions, not to them · program years 2019–2025

Through program year 2020, Kirk Brody of Lakeland, FL is reported in the CMS Open Payments database as having received $10,883 across 35 general payments and $5,688 in research payments paid to them. Separately, studies naming them as principal investigator received $1,396,236 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2020 General $10,614 17
2019 General $269 18
2019 Research $5,688 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kirk Brody
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Kirk Brody were reported at $0. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Kirk Brody Obstetrics & Gynecology median Middle half National median
2019 $269 $172 $62–$391 $163
2020 $10,614 $94 $36–$222 $114
2021 $0 $136 $42–$369 $132
2022 $0 $160 $50–$433 $149
2023 $0 $169 $56–$423 $160
2024 $0 $152 $50–$371 $164
2025 $0 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2020
  1. AEGEA Medical, Inc. $10,415 6 payments
  2. Roche Diagnostics Corporation $93 5 payments
  3. AbbVie, Inc. $63 3 payments
  4. TherapeuticsMD, Inc. $54 4 payments
  5. Lilly USA, LLC $48 3 payments
  6. Axonics Modulation Technologies, Inc. $42 2 payments
  7. Allergan Inc. $39 3 payments
  8. Hologic, LLC $31 2 payments
  9. Pfizer Inc. $30 2 payments
  10. Daiichi Sankyo Inc. $28 2 payments
  11. Other $40 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2020
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,215 5 payments
  2. Consulting Fee $1,200 1 payment
  3. Food and Beverage $468 29 payments
Products named General payments · program years 2019–2020
  1. MARA Water Vapor Ablation System $9,215 5 payments
  2. RS Harmony Test Related Products $93 5 payments
  3. LILETTA $54 3 payments
  4. IMVEXXY $54 4 payments
  5. EMGALITY $48 3 payments
  6. Axonics r-SNM System $42 2 payments
  7. Orilissa $37 2 payments
  8. PREMARIN $30 2 payments
  9. INJECTAFER $28 2 payments
  10. REYVOW $24 1 payment
  11. Other $99 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2020
  1. AEGEA Medical, Inc. $5,688 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Obstetrics & Gynecology: 65

Drug cost

$169

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

0%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Estradiol Generic 11 $169

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Records

36 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2020

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record